SecBot SecBot

ENVB

Enveric Biosciences, Inc.
Nasdaq· Pharmaceutical Preparations· Inc. DE· CIK 0000890821 Biotech & Drug Discovery
$1.40 −0.06 (−4.11%)
Oct 23 4:00 PM ET · prev $1.46
Market cap
$6.5M
Nano cap
Next earnings
Nov 12
in 17 days
1 year
−81.0%
from $7.38 · Oct 27
30 days
−4.8%
from $1.47
52-week range
$1.27–10.33
−86% from high · low Jul 20
Avg volume 20D
60.7K
Oct 14 spike 162.8K
Short interest
🔒 Subscribers only
Insider net
$0
no open-market trades · 12 mo
New fund stakes
0
Q2 2026 13F · 0 exits
Filing reports
7
analyzed by SecBot
SecBot read BEARISH 1 report · 90 days
Balance 1 bearish · 0 bullish oldest → newest, height = score
Avg score ·High conf. 1/1 ·Next Earnings date, Nov 12, 2026
Strongest BEARISH Enveric Biosciences reported a Q2 2026 net loss of $3.0M ($0.76 per share), wider than the $2.5M loss in Q2…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InsidersNO TRADES

    No open-market buys or sells in 12 months. Recent filings are awards, exercises and tax withholding.

  • InstitutionsMIXED

    Q2 2026: 0 added (0 new), 2 trimmed or exited.

  • TrendDOWNTREND

    4% below its 50-day average.

Who's buying

13F· Q2 2026
0
new positions
0
exits
FundMoveSharesValue
GEODE CAPITAL MANAGEMENT, LLCTRIM11,794$16.3K
UBS Group AGNEAR_EXIT201$277.00
UBS Group AGDOUBLED78,408$28.1K

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

last action Mar 2025
Recent actions
DateFirmActionRating
Mar 6, 2025HC Wainwright & Co.
REITERATE
REITERATEBuy
Jan 30, 2024HC Wainwright & Co.
INITIATE
INITIATEBuy
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Nov 12, 2026
Earnings date
ENVB Q3 2026 Earnings Scheduled — 2026-11-12
Recent
Aug 12, 2026
Earnings date
ENVB Q2 2026 Earnings Scheduled — 2026-08-12
May 13, 2026
Earnings date
ENVB Q1 2026 Earnings Scheduled — 2026-05-13
May 12, 2026
Earnings date
ENVB Q1 2026 Earnings Scheduled — 2026-05-12
May 1, 2026
Short interest
FTD: ENVB — 346,235 shares ($1.4M) failed to deliver
Settlement: 20260501, Price: $3.95, FTD Value: $1,367,628.25, ENVERIC BIOSCIENCES INC COM OC
Apr 29, 2026
Short interest
FTD: ENVB — 99,193 shares ($0.5M) failed to deliver
Settlement: 20260429, Price: $5.32, FTD Value: $527,706.76, ENVERIC BIOSCIENCES INC COM OC

Insider ledger

Form 4
$0
open-market buys or sells · 12 mo
DateInsiderTypeValue
Jun 1, 2026
Coveney Kevin Michael
Chief Financial Officer
AWARD133,333 sh
Jun 1, 2026
Tucker Joseph Edward
Chief Executive Officer
AWARD201,124 sh
Jun 1, 2026
PASQUALONE FRANK
Director
AWARD18,518 sh
Jun 1, 2026
DeWitt Sheila
Director
AWARD18,518 sh
Jun 1, 2026
Facchini Peter J.
Chief Innovation Officer
AWARD25,000 sh
Jun 1, 2026
Kegler George A.
Director
AWARD18,518 sh
Jun 1, 2026
Schabacker Marcus
Director
AWARD18,518 sh
Jun 1, 2026
WEBB MICHAEL D
Director
AWARD18,518 sh

Earnings setup

Estimates
Nov 12
reports in 17 days
PeriodEPS est.Range30D rev.Revenue
Current Q———$0.00
Next Q———$0.00
Current FY———$0.00
Next FY———$0.00

Short side

FINRA· Oct 15, 2026
🔒 Subscribers only
shares short
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Aug 14, 2026 SEC
Enveric Biosciences reported a Q2 2026 net loss of $3.0M ($0.76 per share), wider than the $2.5M loss in Q2 2025, but…
8-K — Impact 6/10
Aug 12, 2026 Earnings calendar
ENVB Q2 2026 Earnings Scheduled — 2026-08-12
Jun 30, 2026 Inst.
GEODE CAPITAL MANAGEMENT, LLC — TRIM
11,794 shares ($16.3K)
Jun 30, 2026 Inst.
UBS Group AG — NEAR_EXIT
201 shares ($277.00)
Jun 9, 2026 SEC
Enveric Biosciences filed a prospectus supplement to offer up to $2,425,000 of common stock under its existing ATM…
8-K — Impact 6/10
Jun 9, 2026 SEC
Enveric Biosciences filed a 424B5 prospectus supplement to increase its ATM offering capacity by up to $2,425,000…
424B5 — Impact 7/10
Jun 1, 2026 Insider
Coveney Kevin Michael was granted 133,333 shares
Chief Financial Officer
Jun 1, 2026 Insider
Tucker Joseph Edward was granted 201,124 shares
Chief Executive Officer

SecBot reports

7 filings · 0 bullish · 5 bearish · 2 neutral
All ENVB filing & press-release reports (7)